USE OF ANTI-ANDROGENIC 5Α-REDUCTASE INHIBITORS AND RISK OF OESOPHAGEAL AND GASTRIC CANCER BY HISTOLOGICAL TYPE AND ANATOMICAL SUB-SITE

Giola Santoni  1     Sirus Rabbani  1     Shao-Hua Xie  1     Jesper Lagergren  1    
1 Karolinska Institutet, Stockholm, Sweden

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing